Lv6
2408 积分 2020-08-18 加入
Inebilizumab for Treatment of IgG4-Related Disease
4小时前
待确认
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
4小时前
待确认
Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke
6天前
已完结
Targeting B cells in neuromyelitis optica spectrum disorder
9天前
已完结
Donanemab in Early Symptomatic Alzheimer Disease
16天前
已完结
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD
16天前
已完结
Inebilizumab for Treatment of IgG4-Related Disease
20天前
已完结
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD
20天前
已完结
Arterial stiffness mediates insulin resistance-related risk of atherosclerotic cardiovascular disease: a real-life, prospective cohort study
23天前
已完结
Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
26天前
已完结
皖公网安备34019202002308
